Skip to Content

Join the 'Asfotase Alfa' group to help and get support from people like you.

Asfotase Alfa News

FDA Approves Strensiq (asfotase alfa) for Perinatal, Infantile and Juvenile-Onset Hypophosphatasia

Posted 27 Oct 2015 by

October 23, 2015 – Today, the U.S. Food and Drug Administration approved Strensiq (asfotase alfa) as the first approved treatment for perinatal, infantile and juvenile-onset hypophosphatasia (HPP). HPP is a rare, genetic, progressive, metabolic disease in which patients experience devastating effects on multiple systems of the body, leading to severe disability and life-threatening ...

Ask a Question

Further Information

Related Condition Support Groups


Related Drug Support Groups


Asfotase Alfa Patient Information at